Skip to main content
. 2020 Apr 15;92(7):819–823. doi: 10.1002/jmv.25809

Figure 1.

Figure 1

Levels of CK‐MB, MYO, ultra‐TnI, and NT‐proBNP of the three patients with COVID‐19 groups were compared and analyzed. According to the relevant diagnostic criteria, patients were divided into three groups: mild (n = 198), severe (n = 60), and critical (n = 15). CK‐MB, creatine kinase isoenzyme‐MB; MYO, myohemoglobin; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; COVID, coronavirus disease. ***P < .001